Clinical Supply Logistic Articles
-
Rare Disease Trials: Execution Risks No One Warns You About
10/6/2026
Rare disease trials demand a different approach to site selection, forecasting, supply, and patient logistics because every patient counts. Explore what can go wrong.
-
When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics
10/1/2026
Radiopharmaceuticals turn time into a supply-chain constraint. Short half-lives, patient scheduling, scarce radionuclides and regulatory differences reshape trial logistics.
-
The Patient Is In The Room. Who Is Dispensing The IP?
10/1/2026
Receiving IP is only the beginning. Explore how the first patient visit can expose gaps in dispensing, delegation, IRT, documentation, and site readiness.
-
One IP Receipt Problem Is An Exception. Four Is A Process.
9/30/2026
Repeated IP receipt problems can reveal a site readiness gap. Learn how recurring CRA intervention can expose fragile processes that need to work without rescue.
-
Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
9/29/2026
This fourth installment of our Root Causes video series examines why even the most well-planned clinical trials often push supply and operations into firefighting mode.
-
Your IP Shipment Arrives At 07:00. Who Opens The Box?
9/29/2026
A shipment can arrive on time and within temperature while a site is still unready. See how small handoff gaps can disrupt IP receipt, storage, and accountability.
-
Before The Excursion: The Governance Decisions That Should Already Be Made
9/24/2026
Temperature excursions are inevitable. The real risk is the time lost deciding what to do. See how preplanned governance can turn long quarantines into routine events.
-
Last-Mile Lessons For Depot-To-Site Delivery
9/7/2026
Depot-to-site delivery is more than a courier handoff. See how reconciliation gaps, temperature risks, and mismatched SLAs can turn last-mile issues into trial delays.
-
Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
9/4/2026
Clinical Supply Leader expands its Editorial Advisory Board expertise with the addition of Éamonn McArdle (Allergy Therapeutics) and Juan Hernandez (Bensen Solutions).
-
The Hidden Cost Of The "Cheap" Comparator Drug: Why The Lowest Price Can Become The Most Expensive Choice In Clinical Trials
9/4/2026
The cheapest comparator can become the costliest choice. See how shelf life, logistics, quality, wastage and supply continuity can turn apparent savings into trial risk.